Target intelligence / Profile preview

2'-5'-oligoadenylate synthetase-like protein (OASL)

Target
OASL
Molecular classification
Enzyme (OAS-like family protein, but lacks catalytic synthetase activity), Interferon-stimulated gene product, Pattern recognition molecule
01

Overview

2'-5'-oligoadenylate synthetase-like protein (OASL) is an interferon-inducible enzyme related to the OAS family, predominantly expressed in response to viral infection via IFN signaling[3][4]. While canonical OAS proteins catalyze the synthesis of 2'-5'-linked oligoadenylates that activate RNase L to degrade viral and cellular RNA, human OASL has lost synthetase activity due to changes in its active site[1][3][4]. Instead, OASL contains ubiquitin-like domains at its C-terminus that allow it to mimic polyubiquitin and bind directly to the RIG-I viral RNA sensor, enhancing RIG-I's capacity to induce type I interferons and restrict RNA virus replication[2][3][4]. In DNA virus infection, OASL can inhibit the DNA sensor cGAS, dampening IFN production[1]. OASL is highly dynamic, being upregulated not only by various viruses but also by intracellular pathogenic bacteria, modulating autophagy and antimicrobial peptide secretion and influencing host-pathogen interactions[1]. Variants and polymorphisms in OASL are associated with susceptibility to several viral diseases[3]. There is no evidence of small molecule drugs directly targeting OASL, though its regulation by interferons is therapeutically relevant[4]. OASL is a promising target for modulating innate immunity but poses complexities due to its context-dependent pro- and anti-viral effects[1][2][3][4][5].

Other names
2'-5'-oligoadenylate synthase-like proteinOASLTRIP142'-5'-OAS-RPthyroid receptor-interacting protein 14p59 OASLOASL12'-5'-OAS-related protein59 kDa 2'-5'-oligoadenylate synthetase-like proteinOASLdOASLaOASLb
02

Mechanism of action

For its biological role: Acts as a viral RNA sensor co-factor, enhancing RIG-I-mediated interferon response (by mimicking polyubiquitin). Binds to cytosolic DNA sensor cGAS, inhibiting its activity and interferon signaling (pro-viral role in some DNA virus infections). Upregulated by interferons via IRF3 signaling. Involved in OAS/RNase L pathway activation in avian species.

03

Biological functions

Antiviral defenseimmune responseSignal transduction (interferon pathway)regulation of RIG-I-mediated IFN inductionmodulation of autophagyinhibition of antimicrobial peptide secretion
04

Disease associations

Infection (especially viral diseases such as hepatitis C, West Nile virus, respiratory viruses)InflammationCancer (modulating IFN signaling and immune microenvironment)
05

Safety considerations

Therapeutic targeting would need to consider the dual pro-viral/anti-viral actions depending on viral typepossible implications for immune regulation and autoimmunity
06

Interacting drugs

None known with direct targeting; its expression and function may be indirectly modulated by interferon therapies and some immune modulators
07

Biomarkers

OASL mRNA/protein upregulation can be used as a marker of interferon response and innate anti-viral defensesingle-nucleotide polymorphisms (SNPs) in OASL associated with viral susceptibility

Beyond the preview

Go deeper on 2'-5'-oligoadenylate synthetase-like protein (OASL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-5'-oligoadenylate synthetase-like protein (OASL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call